Free Trial

IO Biotech, Inc. (NASDAQ:IOBT) Short Interest Up 54.8% in March

IO Biotech logo with Medical background
Remove Ads

IO Biotech, Inc. (NASDAQ:IOBT - Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 50,000 shares, a growth of 54.8% from the February 28th total of 32,300 shares. Based on an average daily volume of 177,400 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.1% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. HC Wainwright restated a "buy" rating and set a $12.00 price objective on shares of IO Biotech in a research note on Tuesday. Piper Sandler raised IO Biotech to a "strong-buy" rating in a research note on Wednesday, March 12th.

Check Out Our Latest Research Report on IO Biotech

IO Biotech Trading Down 6.5 %

IOBT stock traded down $0.07 during midday trading on Thursday, hitting $1.00. The stock had a trading volume of 42,925 shares, compared to its average volume of 270,269. The business has a fifty day moving average price of $0.97 and a two-hundred day moving average price of $0.98. IO Biotech has a 1-year low of $0.66 and a 1-year high of $1.79. The firm has a market cap of $65.88 million, a P/E ratio of -0.73 and a beta of 0.22.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of IOBT. XTX Topco Ltd bought a new stake in IO Biotech during the fourth quarter worth $26,000. Vontobel Holding Ltd. bought a new stake in shares of IO Biotech during the fourth quarter valued at about $30,000. Renaissance Technologies LLC lifted its stake in IO Biotech by 22.5% in the 4th quarter. Renaissance Technologies LLC now owns 118,800 shares of the company's stock worth $109,000 after purchasing an additional 21,800 shares in the last quarter. Citadel Advisors LLC purchased a new position in IO Biotech during the fourth quarter worth about $249,000. Finally, Landscape Capital Management L.L.C. purchased a new stake in IO Biotech in the fourth quarter valued at approximately $407,000. Institutional investors and hedge funds own 54.76% of the company's stock.

Remove Ads

IO Biotech Company Profile

(Get Free Report)

IO Biotech, Inc, a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer.

Read More

Should You Invest $1,000 in IO Biotech Right Now?

Before you consider IO Biotech, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IO Biotech wasn't on the list.

While IO Biotech currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Donald Trump Owns These 7 Stocks, Should You?

Donald Trump Owns These 7 Stocks, Should You?

He’s one of the most talked-about billionaires in the world—but when it comes to investing, Donald Trump’s stock picks are shockingly… low-key.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
Donald Trump Owns These 7 Stocks, Should You?
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads